Blood Glucose Device-EMEA Market Status and Trend Report 2013-2023
Report Summary
Blood Glucose Device-EMEA Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Blood Glucose Device industry, standing on the readers’ perspective, delivering detailed market data and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:
Whole EMEA and Regional Market Size of Blood Glucose Device 2013-2017, and development forecast 2018-2023
Main market players of Blood Glucose Device in EMEA, with company and product introduction, position in the Blood Glucose Device market
Market status and development trend of Blood Glucose Device by types and applications
Cost and profit status of Blood Glucose Device, and marketing status
Market growth drivers and challenges
The report segments the EMEA Blood Glucose Device market as:
EMEA Blood Glucose Device Market: Regional Segment Analysis (Regional Consumption Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):
Europe
Middle East
Africa
EMEA Blood Glucose Device Market: Product Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):
Blood Glucose Monitors
Glucose Monitoring Strips
Lancets
EMEA Blood Glucose Device Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)
Hospitals
Diagnostics
Home Settings
Others
EMEA Blood Glucose Device Market: Players Segment Analysis (Company and Product introduction, Blood Glucose Device Sales Volume, Revenue, Price and Gross Margin):
Abbott Laboratories (U.S.)
ARKRAY (Japan)
Dexcom (U.S.)
F.Hoffmann-La Roche Ltd (Switzerland)
Johnson & Johnson (U.S.)
Medtronic (U.S.)
Nipro Diagnostics (U.S.)
Terumo Medical Corporation (U.S.)
In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
Blood Glucose Device-EMEA Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Blood Glucose Device industry, standing on the readers’ perspective, delivering detailed market data and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:
Whole EMEA and Regional Market Size of Blood Glucose Device 2013-2017, and development forecast 2018-2023
Main market players of Blood Glucose Device in EMEA, with company and product introduction, position in the Blood Glucose Device market
Market status and development trend of Blood Glucose Device by types and applications
Cost and profit status of Blood Glucose Device, and marketing status
Market growth drivers and challenges
The report segments the EMEA Blood Glucose Device market as:
EMEA Blood Glucose Device Market: Regional Segment Analysis (Regional Consumption Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):
Europe
Middle East
Africa
EMEA Blood Glucose Device Market: Product Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):
Blood Glucose Monitors
Glucose Monitoring Strips
Lancets
EMEA Blood Glucose Device Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)
Hospitals
Diagnostics
Home Settings
Others
EMEA Blood Glucose Device Market: Players Segment Analysis (Company and Product introduction, Blood Glucose Device Sales Volume, Revenue, Price and Gross Margin):
Abbott Laboratories (U.S.)
ARKRAY (Japan)
Dexcom (U.S.)
F.Hoffmann-La Roche Ltd (Switzerland)
Johnson & Johnson (U.S.)
Medtronic (U.S.)
Nipro Diagnostics (U.S.)
Terumo Medical Corporation (U.S.)
In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
CHAPTER 1 OVERVIEW OF BLOOD GLUCOSE DEVICE
1.1 Definition of Blood Glucose Device in This Report
1.2 Commercial Types of Blood Glucose Device
1.2.1 Blood Glucose Monitors
1.2.2 Glucose Monitoring Strips
1.2.3 Lancets
1.3 Downstream Application of Blood Glucose Device
1.3.1 Hospitals
1.3.2 Diagnostics
1.3.3 Home Settings
1.3.4 Others
1.4 Development History of Blood Glucose Device
1.5 Market Status and Trend of Blood Glucose Device 2013-2023
1.5.1 EMEA Blood Glucose Device Market Status and Trend 2013-2023
1.5.2 Regional Blood Glucose Device Market Status and Trend 2013-2023
CHAPTER 2 EMEA MARKET STATUS AND FORECAST BY REGIONS
2.1 Market Status of Blood Glucose Device in EMEA 2013-2017
2.2 Consumption Market of Blood Glucose Device in EMEA by Regions
2.2.1 Consumption Volume of Blood Glucose Device in EMEA by Regions
2.2.2 Revenue of Blood Glucose Device in EMEA by Regions
2.3 Market Analysis of Blood Glucose Device in EMEA by Regions
2.3.1 Market Analysis of Blood Glucose Device in Europe 2013-2017
2.3.2 Market Analysis of Blood Glucose Device in Middle East 2013-2017
2.3.3 Market Analysis of Blood Glucose Device in Africa 2013-2017
2.4 Market Development Forecast of Blood Glucose Device in EMEA 2018-2023
2.4.1 Market Development Forecast of Blood Glucose Device in EMEA 2018-2023
2.4.2 Market Development Forecast of Blood Glucose Device by Regions 2018-2023
CHAPTER 3 EMEA MARKET STATUS AND FORECAST BY TYPES
3.1 Whole EMEA Market Status by Types
3.1.1 Consumption Volume of Blood Glucose Device in EMEA by Types
3.1.2 Revenue of Blood Glucose Device in EMEA by Types
3.2 EMEA Market Status by Types in Major Countries
3.2.1 Market Status by Types in Europe
3.2.2 Market Status by Types in Middle East
3.2.3 Market Status by Types in Africa
3.3 Market Forecast of Blood Glucose Device in EMEA by Types
CHAPTER 4 EMEA MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY
4.1 Demand Volume of Blood Glucose Device in EMEA by Downstream Industry
4.2 Demand Volume of Blood Glucose Device by Downstream Industry in Major Countries
4.2.1 Demand Volume of Blood Glucose Device by Downstream Industry in Europe
4.2.2 Demand Volume of Blood Glucose Device by Downstream Industry in Middle East
4.2.3 Demand Volume of Blood Glucose Device by Downstream Industry in Africa
4.3 Market Forecast of Blood Glucose Device in EMEA by Downstream Industry
CHAPTER 5 MARKET DRIVING FACTOR ANALYSIS OF BLOOD GLUCOSE DEVICE
5.1 EMEA Economy Situation and Trend Overview
5.2 Blood Glucose Device Downstream Industry Situation and Trend Overview
CHAPTER 6 BLOOD GLUCOSE DEVICE MARKET COMPETITION STATUS BY MAJOR PLAYERS IN EMEA
6.1 Sales Volume of Blood Glucose Device in EMEA by Major Players
6.2 Revenue of Blood Glucose Device in EMEA by Major Players
6.3 Basic Information of Blood Glucose Device by Major Players
6.3.1 Headquarters Location and Established Time of Blood Glucose Device Major Players
6.3.2 Employees and Revenue Level of Blood Glucose Device Major Players
6.4 Market Competition News and Trend
6.4.1 Merger, Consolidation or Acquisition News
6.4.2 Investment or Disinvestment News
6.4.3 New Product Development and Launch
CHAPTER 7 BLOOD GLUCOSE DEVICE MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA
7.1 Abbott Laboratories (U.S.)
7.1.1 Company profile
7.1.2 Representative Blood Glucose Device Product
7.1.3 Blood Glucose Device Sales, Revenue, Price and Gross Margin of Abbott Laboratories (U.S.)
7.2 ARKRAY (Japan)
7.2.1 Company profile
7.2.2 Representative Blood Glucose Device Product
7.2.3 Blood Glucose Device Sales, Revenue, Price and Gross Margin of ARKRAY (Japan)
7.3 Dexcom (U.S.)
7.3.1 Company profile
7.3.2 Representative Blood Glucose Device Product
7.3.3 Blood Glucose Device Sales, Revenue, Price and Gross Margin of Dexcom (U.S.)
7.4 F.Hoffmann-La Roche Ltd (Switzerland)
7.4.1 Company profile
7.4.2 Representative Blood Glucose Device Product
7.4.3 Blood Glucose Device Sales, Revenue, Price and Gross Margin of F.Hoffmann-La Roche Ltd (Switzerland)
7.5 Johnson & Johnson (U.S.)
7.5.1 Company profile
7.5.2 Representative Blood Glucose Device Product
7.5.3 Blood Glucose Device Sales, Revenue, Price and Gross Margin of Johnson & Johnson (U.S.)
7.6 Medtronic (U.S.)
7.6.1 Company profile
7.6.2 Representative Blood Glucose Device Product
7.6.3 Blood Glucose Device Sales, Revenue, Price and Gross Margin of Medtronic (U.S.)
7.7 Nipro Diagnostics (U.S.)
7.7.1 Company profile
7.7.2 Representative Blood Glucose Device Product
7.7.3 Blood Glucose Device Sales, Revenue, Price and Gross Margin of Nipro Diagnostics (U.S.)
7.8 Terumo Medical Corporation (U.S.)
7.8.1 Company profile
7.8.2 Representative Blood Glucose Device Product
7.8.3 Blood Glucose Device Sales, Revenue, Price and Gross Margin of Terumo Medical Corporation (U.S.)
CHAPTER 8 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF BLOOD GLUCOSE DEVICE
8.1 Industry Chain of Blood Glucose Device
8.2 Upstream Market and Representative Companies Analysis
8.3 Downstream Market and Representative Companies Analysis
CHAPTER 9 COST AND GROSS MARGIN ANALYSIS OF BLOOD GLUCOSE DEVICE
9.1 Cost Structure Analysis of Blood Glucose Device
9.2 Raw Materials Cost Analysis of Blood Glucose Device
9.3 Labor Cost Analysis of Blood Glucose Device
9.4 Manufacturing Expenses Analysis of Blood Glucose Device
CHAPTER 10 MARKETING STATUS ANALYSIS OF BLOOD GLUCOSE DEVICE
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List
CHAPTER 11 REPORT CONCLUSION
CHAPTER 12 RESEARCH METHODOLOGY AND REFERENCE
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Reference
1.1 Definition of Blood Glucose Device in This Report
1.2 Commercial Types of Blood Glucose Device
1.2.1 Blood Glucose Monitors
1.2.2 Glucose Monitoring Strips
1.2.3 Lancets
1.3 Downstream Application of Blood Glucose Device
1.3.1 Hospitals
1.3.2 Diagnostics
1.3.3 Home Settings
1.3.4 Others
1.4 Development History of Blood Glucose Device
1.5 Market Status and Trend of Blood Glucose Device 2013-2023
1.5.1 EMEA Blood Glucose Device Market Status and Trend 2013-2023
1.5.2 Regional Blood Glucose Device Market Status and Trend 2013-2023
CHAPTER 2 EMEA MARKET STATUS AND FORECAST BY REGIONS
2.1 Market Status of Blood Glucose Device in EMEA 2013-2017
2.2 Consumption Market of Blood Glucose Device in EMEA by Regions
2.2.1 Consumption Volume of Blood Glucose Device in EMEA by Regions
2.2.2 Revenue of Blood Glucose Device in EMEA by Regions
2.3 Market Analysis of Blood Glucose Device in EMEA by Regions
2.3.1 Market Analysis of Blood Glucose Device in Europe 2013-2017
2.3.2 Market Analysis of Blood Glucose Device in Middle East 2013-2017
2.3.3 Market Analysis of Blood Glucose Device in Africa 2013-2017
2.4 Market Development Forecast of Blood Glucose Device in EMEA 2018-2023
2.4.1 Market Development Forecast of Blood Glucose Device in EMEA 2018-2023
2.4.2 Market Development Forecast of Blood Glucose Device by Regions 2018-2023
CHAPTER 3 EMEA MARKET STATUS AND FORECAST BY TYPES
3.1 Whole EMEA Market Status by Types
3.1.1 Consumption Volume of Blood Glucose Device in EMEA by Types
3.1.2 Revenue of Blood Glucose Device in EMEA by Types
3.2 EMEA Market Status by Types in Major Countries
3.2.1 Market Status by Types in Europe
3.2.2 Market Status by Types in Middle East
3.2.3 Market Status by Types in Africa
3.3 Market Forecast of Blood Glucose Device in EMEA by Types
CHAPTER 4 EMEA MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY
4.1 Demand Volume of Blood Glucose Device in EMEA by Downstream Industry
4.2 Demand Volume of Blood Glucose Device by Downstream Industry in Major Countries
4.2.1 Demand Volume of Blood Glucose Device by Downstream Industry in Europe
4.2.2 Demand Volume of Blood Glucose Device by Downstream Industry in Middle East
4.2.3 Demand Volume of Blood Glucose Device by Downstream Industry in Africa
4.3 Market Forecast of Blood Glucose Device in EMEA by Downstream Industry
CHAPTER 5 MARKET DRIVING FACTOR ANALYSIS OF BLOOD GLUCOSE DEVICE
5.1 EMEA Economy Situation and Trend Overview
5.2 Blood Glucose Device Downstream Industry Situation and Trend Overview
CHAPTER 6 BLOOD GLUCOSE DEVICE MARKET COMPETITION STATUS BY MAJOR PLAYERS IN EMEA
6.1 Sales Volume of Blood Glucose Device in EMEA by Major Players
6.2 Revenue of Blood Glucose Device in EMEA by Major Players
6.3 Basic Information of Blood Glucose Device by Major Players
6.3.1 Headquarters Location and Established Time of Blood Glucose Device Major Players
6.3.2 Employees and Revenue Level of Blood Glucose Device Major Players
6.4 Market Competition News and Trend
6.4.1 Merger, Consolidation or Acquisition News
6.4.2 Investment or Disinvestment News
6.4.3 New Product Development and Launch
CHAPTER 7 BLOOD GLUCOSE DEVICE MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA
7.1 Abbott Laboratories (U.S.)
7.1.1 Company profile
7.1.2 Representative Blood Glucose Device Product
7.1.3 Blood Glucose Device Sales, Revenue, Price and Gross Margin of Abbott Laboratories (U.S.)
7.2 ARKRAY (Japan)
7.2.1 Company profile
7.2.2 Representative Blood Glucose Device Product
7.2.3 Blood Glucose Device Sales, Revenue, Price and Gross Margin of ARKRAY (Japan)
7.3 Dexcom (U.S.)
7.3.1 Company profile
7.3.2 Representative Blood Glucose Device Product
7.3.3 Blood Glucose Device Sales, Revenue, Price and Gross Margin of Dexcom (U.S.)
7.4 F.Hoffmann-La Roche Ltd (Switzerland)
7.4.1 Company profile
7.4.2 Representative Blood Glucose Device Product
7.4.3 Blood Glucose Device Sales, Revenue, Price and Gross Margin of F.Hoffmann-La Roche Ltd (Switzerland)
7.5 Johnson & Johnson (U.S.)
7.5.1 Company profile
7.5.2 Representative Blood Glucose Device Product
7.5.3 Blood Glucose Device Sales, Revenue, Price and Gross Margin of Johnson & Johnson (U.S.)
7.6 Medtronic (U.S.)
7.6.1 Company profile
7.6.2 Representative Blood Glucose Device Product
7.6.3 Blood Glucose Device Sales, Revenue, Price and Gross Margin of Medtronic (U.S.)
7.7 Nipro Diagnostics (U.S.)
7.7.1 Company profile
7.7.2 Representative Blood Glucose Device Product
7.7.3 Blood Glucose Device Sales, Revenue, Price and Gross Margin of Nipro Diagnostics (U.S.)
7.8 Terumo Medical Corporation (U.S.)
7.8.1 Company profile
7.8.2 Representative Blood Glucose Device Product
7.8.3 Blood Glucose Device Sales, Revenue, Price and Gross Margin of Terumo Medical Corporation (U.S.)
CHAPTER 8 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF BLOOD GLUCOSE DEVICE
8.1 Industry Chain of Blood Glucose Device
8.2 Upstream Market and Representative Companies Analysis
8.3 Downstream Market and Representative Companies Analysis
CHAPTER 9 COST AND GROSS MARGIN ANALYSIS OF BLOOD GLUCOSE DEVICE
9.1 Cost Structure Analysis of Blood Glucose Device
9.2 Raw Materials Cost Analysis of Blood Glucose Device
9.3 Labor Cost Analysis of Blood Glucose Device
9.4 Manufacturing Expenses Analysis of Blood Glucose Device
CHAPTER 10 MARKETING STATUS ANALYSIS OF BLOOD GLUCOSE DEVICE
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List
CHAPTER 11 REPORT CONCLUSION
CHAPTER 12 RESEARCH METHODOLOGY AND REFERENCE
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Reference
